Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of Tuesday, October 6, 2026.
EARNINGS PER SHARE (EPS)
N/A
Conexeu Sciences Inc.
Market Cap
$97.94M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$97.90M
Earnings Per Share (EPS)
-1.48
TTM Avg
-3.50
3Y Avg
-21.30
5Y Avg
-30.60
Market Cap
$97.14M
Earnings Per Share (EPS)
-10.01
TTM Avg
-10.93
3Y Avg
-75.63
5Y Avg
-58.09
Market Cap
$99.62M
Earnings Per Share (EPS)
-3.50
TTM Avg
-4.18
3Y Avg
-3.30
5Y Avg
-7.15
Market Cap
$95.14M
Earnings Per Share (EPS)
-0.69
TTM Avg
-0.71
3Y Avg
-1.04
5Y Avg
-1.15
Market Cap
$101.36M
Earnings Per Share (EPS)
0.27
TTM Avg
-0.10
3Y Avg
-0.20
5Y Avg
0.10
Market Cap
$93.96M
Earnings Per Share (EPS)
-0.91
TTM Avg
0.49
3Y Avg
1.23
5Y Avg
1.23
Market Cap
$102.75M
Earnings Per Share (EPS)
-0.30
TTM Avg
-0.36
3Y Avg
-0.38
5Y Avg
-0.40
Market Cap
$103.14M
Earnings Per Share (EPS)
-0.74
TTM Avg
-0.44
3Y Avg
-1.32
5Y Avg
-1.80
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | $97.94M | N/A | N/A | N/A | N/A |
| PolyPid Ltd. (PYPD)vs › | $97.90M | -1.48 | -3.50 | -21.30 | -30.60 |
| Korro Bio, Inc. (KRRO)vs › | $97.14M | -10.01 | -10.93 | -75.63 | -58.09 |
| OnKure Therapeutics, Inc. (OKUR)vs › | $99.62M | -3.50 | -4.18 | -3.30 | -7.15 |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $95.14M | -0.69 | -0.71 | -1.04 | -1.15 |
| The Joint Corp. (JYNT)vs › | $101.36M | 0.27 | -0.10 | -0.20 | 0.10 |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.96M | -0.91 | 0.49 | 1.23 | 1.23 |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.75M | -0.30 | -0.36 | -0.38 | -0.40 |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $103.14M | -0.74 | -0.44 | -1.32 | -1.80 |
| Definitive Healthcare Corp. (DH)vs › | $104.26M | -1.60 | -2.42 | -1.68 | -1.45 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
